Evidence map›Paper›PMID 35145489›Full record

ArticleFrontiers in microbiology2021

Molecular Characterization of

Lina Reslan, George F Araj, Marc Finianos, Rima El Asmar, Jaroslav Hrabak, Ghassan Dbaibo, Ibrahim Bitar

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.1field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Article
  3. First draft genome sequence ofMicrobiology resource announcements · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. The multidrug-resistantCurrent research in microbial sciences · 2025
    Review
  8. Current issues in molecular biology · 2024
    Review
  9. Genomic characterization of ST38 NDM-5-producingAntimicrobial agents and chemotherapy · 2024
    Article
  10. Comparative Genomics of the First ResistantJournal of fungi (Basel, Switzerland) · 2024
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. COVID-19 andMicroorganisms · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lina ReslanAmerican University of Beirut, Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut, Lebanon.
George F ArajAmerican University of Beirut, Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut, Lebanon.
Marc FinianosDepartment of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University, Plzeň, Czechia.
Rima El AsmarDepartment of Pathology and Laboratory Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
Jaroslav HrabakDepartment of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University, Plzeň, Czechia.
Ghassan DbaiboAmerican University of Beirut, Center for Infectious Diseases Research (CIDR) and WHO Collaborating Center for Reference and Research on Bacterial Pathogens, Beirut, Lebanon.
Ibrahim BitarDepartment of Microbiology, Faculty of Medicine and University Hospital in Plzen, Charles University, Plzeň, Czechia.
American University of Beirut · LBCharles University · CZAmerican University of Beirut Medical Center · LB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe globally emerging

methodsA total of 28

results

conclusionThis characterization of

Indexed as

antifungal resistanceCandida aurisLebanonSouth Asian cladewhole-genome sequencing

Identifiers

PMID35145489
PMCPMC8822126
OpenAlexW4206961073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.